(Mealey's) Merck Sharp & Dohme Corp. and plaintiffs' counsel in four Canadian Vioxx class actions announced Jan. 19 that they have agreed to settle the litigation for up to $36.3 million ( Mignacca, et al. v. Merck Frosst Canada Ltd, et al... Read More

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on April 27 affirmed a Third Circuit U.S. Court of Appeals ruling that a shareholder derivative lawsuit over Merck & Co. Inc.'s marketing of Vioxx was timely and held that the statute of... Read More

PHILADELPHIA - (Mealey's) A federal judge in Pennsylvania on July 20 dismissed a putative consumer class action that alleged fraudulent marketing of 12 Pfizer Inc. drugs, saying that the plaintiffs failed to demonstrate an injury or reliance upon... Read More

SYDNEY, Australia – (AP) The once-popular painkiller Vioxx doubled the risk of heart attack and was unfit for consumption, an Australian court ruled Friday, awarding a man leading a class action suit against the drug's maker 287,000 Australian... Read More

WASHINGTON, D.C. – (AP) The Supreme Court said Tuesday investors who lost millions betting on the blockbuster drug Vioxx can sue Merck & Co. over whether the pharmaceutical giant provided enough information about the painkiller's risks before... Read More